Giant Biogene Holding Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6,306	4,030	2,504	1,331	7,103
Short-Term Investments	38.08	19.5	11.03	21.31	4.88
Trading Asset Securities	1,984	1,829	1,275	865.97	155.61
Cash & Short-Term Investments	8,329	5,878	3,790	2,218	7,263
Cash Growth	41.68%	55.11%	70.85%	-69.46%	270.86%
Accounts Receivable	201.87	141.28	102.03	69.42	65.64
Other Receivables	27.06	7.34	14.55	4.6	6.7
Receivables	228.92	148.62	116.57	74.02	72.34
Inventory	391.07	310.81	200.44	183.9	89.39
Other Current Assets	69.99	64.17	28.26	61.58	16.11
Total Current Assets	9,019	6,402	4,135	2,538	7,441
Property, Plant & Equipment	1,257	1,093	711.62	551.65	333.53
Long-Term Investments	420.53	451.84	-	-	-
Other Intangible Assets	4.98	5.82	7.36	6.75	7.6
Long-Term Deferred Tax Assets	0.52	0.91	1.11	1.19	1.35
Other Long-Term Assets	140.12	84.65	117.91	40.9	94.41
Total Assets	10,841	8,038	4,973	3,138	7,878
Accounts Payable	198.57	286.71	133.11	54.65	23.61
Accrued Expenses	73.36	61.36	40.72	28.5	28.93
Current Portion of Leases	6.43	4.7	1.56	0.88	-
Current Income Taxes Payable	70.35	117.02	116.72	75.02	71.36
Current Unearned Revenue	19.38	18.68	37.25	13.95	17.78
Other Current Liabilities	431.89	347.53	201.25	107.9	6,701
Total Current Liabilities	799.96	836	530.61	280.91	6,843
Long-Term Leases	3.26	2.01	1.17	1.71	-
Long-Term Unearned Revenue	16.32	18.93	19.58	18.18	17.58
Long-Term Deferred Tax Liabilities	97.09	61.2	50.68	0.4	0.77
Total Liabilities	916.64	918.14	602.03	301.19	6,861
Common Stock	0.07	0.07	0.06	0.06	0.06
Additional Paid-In Capital	-	2,736	1,695	1,597	7,160
Retained Earnings	-	4,229	2,619	1,167	164.8
Treasury Stock	-166.15	-0	-0	-0	-0
Comprehensive Income & Other	10,078	143.53	48.81	69.72	-6,308
Total Common Equity	9,911	7,108	4,362	2,833	1,017
Minority Interest	13.31	11.61	8.91	3.56	-
Shareholders' Equity	9,925	7,120	4,371	2,837	1,017
Total Liabilities & Equity	10,841	8,038	4,973	3,138	7,878
Total Debt	9.69	6.71	2.73	2.59	-
Net Cash (Debt)	8,319	5,872	3,787	2,216	7,263
Net Cash Growth	41.68%	55.04%	70.92%	-69.50%	270.86%
Net Cash Per Share	7.85	5.86	3.85	2.17	7.26
Filing Date Shares Outstanding	1,066	1,016	976	976	900
Total Common Shares Outstanding	1,066	1,016	976	976	900
Working Capital	8,219	5,566	3,604	2,257	598.28
Book Value Per Share	9.30	7.00	4.47	2.90	1.13
Tangible Book Value	9,906	7,102	4,355	2,827	1,009
Tangible Book Value Per Share	9.30	6.99	4.46	2.90	1.12
Buildings	-	580.02	285.49	225.79	184.61
Machinery	-	214.6	131.75	104.62	69.28
Construction In Progress	-	387.88	356.25	244.44	81.58
Leasehold Improvements	-	21.69	9.54	5.56	1.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.